Drug-induced long QT in isolated rabbit Purkinje fibers: Importance of action potential duration, triangulation and early afterdepolarizations

European Journal of Pharmacology

Volumn 452, Issue 2, 2002, Pages 183-192

  Lu, Hua Rong ^a   Vlaminckx, Eddy ^a   Van Ammel, Karel ^a   De Clerck, Fred ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

Afterdepolarization, early; APD (action potential duration); Long QT syndrome; Purkinje fiber, rabbit; Triangulation

Indexed keywords

ANTHOPLEURIN A; DOFETILIDE; INDAPAMIDE; ISOPRENALINE; SOLVENT;

ACTION POTENTIAL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; HEART DEPOLARIZATION; LONG QT SYNDROME; NONHUMAN; PRIORITY JOURNAL; PURKINJE FIBER; RABBIT;

ACTION POTENTIALS; ANIMALS; FEMALE; LONG QT SYNDROME; PURKINJE FIBERS; RABBITS;

EID: 0037020439     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02246-X     Document Type: Article

References (29)

1. Abrahamsson C., Carlsson L., Duker G. Lidocaine and nisoldipine attenuate almokalant-induced dispersion of repolarization and early afterdepolarizations in vitro. J. Cardiovasc. Electrophysiol. 7:1996;1074-1081.
2. Adamantidis M.M., Lacroix D.L., Caron J.F., Dupuis B.A. Electrophysiological and arrhythmogenic effects of the histamine type1-receptor antagonist astemizole on rabbit Purkinje fibers: clinical relevance. J. Cardiovasc. Pharmacol. 26:1995;319-327.
3. Adamantidis M.M., Dumotier B.M., Caron J.F., Bordet R. Sparfloxacin but not levofloxacin or ofloxacin prolongs cardiac repolarization in rabbit Purkinje fibers. Fundam. Clin. Pharmacol. 12(1):1998;70-76.
4. Anonymous, 1997. Points to Consider: The Assessment of the Potential for QT Interval Prolongation by Non-cardiovascular Medicinal Products. Publication no. CPMP 986-996. Committee for Proprietary Medicinal Products (CPMP) Human Medicines Evaluation Unit, London, UK.
5. Antzelevitch C. Heterogeneity of cellular repolarization in LQTs: the role of M cells. Eur. Heart J. 3(Suppl. K):2001;K2-K16.
6. ks does not induce early afterdepolarization activity but promotes β-adrenergic agonist-induced delayed afterdepolarization activity. J. Cardiovasc. Electrophysiol. 11:2000;458-465.
7. Carlsson L., Amos G.J., Andersson B.et al. Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: implications for proarrhythmic potential? J. Pharmacol. Exp. Ther. 282:1997;220-227.
8. Chiang C.E., Roden D.M. The long QT syndromes: genetic basis and clinical implications. J. Am. Cardiol. 36:2000;1-12.
9. + currents in rabbit heart Purkinje fiber cells. J. Physiol. 508(Pt. 3):1998;811-823.
10. Damiano B.P., Rosen M.R. Effects of pacing on triggered activity induced by early afterdepolarizations. Circulation. 69:1984;1013-1025.
11. De Clerck F., Van de Water A., D'Aubioul J., Lu H.R., van Roosem K., Hermans A., Van Ammel K. In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: application to the preclinical cardiovascular safety pharmacology of a new chemical entity. Fundam. Clin. Pharmacol. 16:2002;125-140.
12. Haverkamp W., Breithardt G., Camm A.J., Janse M.J., Rosen M.R., Antzelevitch C., Escande D., Franz M., Malik M., Moss A., Shah R. The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Eur. Heart J. 21:2000;1216-1231.
13. Hondeghem L.M., Dujardin K., De Clerck F. Phase 2 prolongation, in the absence of instability and triangulation, antagonizes class III proarrhythmia. Cardiovasc. Res. 50:2001;345-353.
14. January C.T., Chau V., Makielski J.C. Triggered activity in the heart: cellular mechanisms of early after-depolarizations. Eur. Heart J. 12(Suppl. F):1991;4-9.
15. Keating M.T. Genetic approaches to cardiovascular disease, supralvulvar aortic stenosis, Williams syndromes, and long-QT syndrome. Circulation. 92:1995;142-147.
16. ks) fails to lengthen rabbit ventricular muscle QTc and action potential duration. Br. J. Pharmacol. 32:2001;101-110.
17. Lu H.R., Mariën R., Saels A., De Clerck F. Are there sex specific differences in ventricular repolarization or in drug-induced early afterdepolarizations in isolated rabbit Purkinje fibers? Cardiovasc. Pharmacol. 36:2000;132-139.
18. Lu H.R., Mariën R., Saels A., De Clerck F. Species plays an important role in drug-induced prolongation of action potential duration and early afterdepolarizations in isolated Purkinje fibers. J. Cardiovasc. Electrophysiol. 12:2001;93-102.
19. + channel blockade, beta-adrenergic stimulation, and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long-QT syndrome. Circ. Res. 78(6):1996;1009-1015.
20. Priori S.G., Napolitano C., Paganini V., Cantu F., Schwartz P.J. Molecular biology of the long QT syndrome: impact on management. Pacing Clin. Electrophysiol. 20(8):1997;2052-2057.
21. Priori S.G., Barhanin J., Hauer R.N., Haverkamp W., Jongsma H.J., Kleber A.G. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II. Circulation. 99:1999;518-528.
22. Rosen M.R. Isolated tissue models and proarrhythmia. Eur. Heart J. 3(Suppl. K):2001;K64-K69.
23. Schechter E., Freeman C.C., Lazzara R. Afterdepolarizations as a mechanism for the long QT syndrome: electrophysiologic studies of a case. J. Am. Coll. Cardiol. 3:1984;1556-1561.
24. Shimizu W., Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing Torsade de Pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation. 96:1997;2038-2047.
25. Shimizu W., Antzelevitch C. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J. Am. Coll. Cardiol. 35:2000;778-786.
26. Studenik C.R., Zhou Z., January C.T. Differences in action potential and early afterdepolarization properties in LQT2 and LQT3 models of long QT syndrome. Br. J. Pharmacol. 132:2001;85-92.
27. + current, by the diuretic agent indapamide in guinea-pig myocytes. Circ. Res. 75:1994;879-886.
28. ks in dog ventricular muscle and Purkinje fiber repolarization. J. Physiol. 523(Pt. 1):2000;67-81.
29. Vincent G.M. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death. Annu. Rev. Med. 49:1998;263-274.